Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Quanex Building Products CORPNX · Entity 5077 | VP CAO Controller | December 19, 2022 | December 20, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Quanex Building Products CORP
Report date December 19, 2022 · Filed December 20, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,063 |
Ending reported balance
After 2022-12-19 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-12-19 · Grant · Acquired 2,521 · Balance 17,677 F1: On December 5, 2019, the reporting person was granted a target number of performance restricted stock units, with a potential payout from 0% to 150% of target based on the Company's absolute total shareholder return over the three year period from November 1, 2019 through October 31, 2022. The payout amount was finalized on December 17, 2022, resulting in the issuance of common stock on December 19, 2022. Row 2 · 2022-12-19 · Tax withholding · Disposed 614 · Balance 17,063 F2: Shares were withheld to cover taxes due in connection with the grant of common stock relating to the vesting of Performance Restricted Stock Units originally granted on December 5, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 5, 2019, the reporting person was granted a target number of performance restricted stock units, with a potential payout from 0% to 150% of target based on the Company's absolute total shareholder return over the three year period from November 1, 2019 through October 31, 2022. The payout amount was finalized on December 17, 2022, resulting in the issuance of common stock on December 19, 2022.
F2: Shares were withheld to cover taxes due in connection with the grant of common stock relating to the vesting of Performance Restricted Stock Units originally granted on December 5, 2019.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
OMEGA PROTEIN CORP
Report date December 19, 2017 · Filed December 21, 2017
Section 16 reporting ended · disclosed 2017-12-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-12-19 transaction · row 1
1 source rowRow 1 · 2017-12-19 · Disposition to issuer · Disposed 6,224 · Balance 0 F1: Includes shares of common stock (the "Common Stock") of Omega Protein Corporation (the "Company") held by the Reporting Person and awards of shares of restricted Common Stock previously granted, 4,032 shares of which vested immediately prior to the effective time of the Merger (as defined below). F2: On December 19, 2017, pursuant to the Agreement and Plan of Merger dated as of October 5, 2017 (the "Merger Agreement"), by and among the Company, Cooke Inc. ("Cooke") and Alpha MergerSub, Inc. ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger") with the Company continuing as the surviving entity and a wholly-owned indirect subsidiary of Cooke. Pursuant to the Merger Agreement, each share of Common Stock of the Company issued and outstanding immediately prior to the effective time of the merger was automatically cancelled and converted into the right to the receive $22.00 in cash, less any required tax withholdings. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes shares of common stock (the "Common Stock") of Omega Protein Corporation (the "Company") held by the Reporting Person and awards of shares of restricted Common Stock previously granted, 4,032 shares of which vested immediately prior to the effective time of the Merger (as defined below).
F2: On December 19, 2017, pursuant to the Agreement and Plan of Merger dated as of October 5, 2017 (the "Merger Agreement"), by and among the Company, Cooke Inc. ("Cooke") and Alpha MergerSub, Inc. ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger") with the Company continuing as the surviving entity and a wholly-owned indirect subsidiary of Cooke. Pursuant to the Merger Agreement, each share of Common Stock of the Company issued and outstanding immediately prior to the effective time of the merger was automatically cancelled and converted into the right to the receive $22.00 in cash, less any required tax withholdings.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 19, 2022 Filed Dec 20, 2022 21:32 UTC | Quanex Building Products CORP NX · Entity 5077 | Tax withholdingCommon Stock | 614 | $23.80 | $14,613.20 |
DisclosureSEC source: 0001127602-22-027967 · form4.xml · nonDerivative · entry 2 LIVINGSTON MARK A · CIK 0001651202 · VP CAO Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,063 F2 · kind: Shares were withheld to cover taxes due in connection with the grant of common stock relating to the vesting of Performance Restricted Stock Units originally granted on December 5, 2019. Read SEC document |
| December 19, 2022 Filed Dec 20, 2022 21:32 UTC | Quanex Building Products CORP NX · Entity 5077 | GrantCommon Stock | 2,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-027967 · form4.xml · nonDerivative · entry 1 LIVINGSTON MARK A · CIK 0001651202 · VP CAO Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,677 F1 · kind: On December 5, 2019, the reporting person was granted a target number of performance restricted stock units, with a potential payout from 0% to 150% of target based on the Company's absolute total shareholder return over the three year period from November 1, 2019 through October 31, 2022. The payout amount was finalized on December 17, 2022, resulting in the issuance of common stock on December 19, 2022. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 21:19 UTC | Quanex Building Products CORP NX · Entity 5077 | GrantCommon Stock | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-027185 · form4.xml · nonDerivative · entry 1 LIVINGSTON MARK A · CIK 0001651202 · VP CAO Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,156 Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 22:17 UTC | Quanex Building Products CORP NX · Entity 5077 | Tax withholdingCommon Stock | 609 | $23.84 | $14,518.56 |
DisclosureSEC source: 0001127602-22-026985 · form4.xml · nonDerivative · entry 1 LIVINGSTON MARK A · CIK 0001651202 · VP CAO Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,656 F1 · shares: Shares were sold to cover taxes due in connection with the lapse of forfeiture restrictions on restricted stock originally granted to the reporting person on December 5, 2019. Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 21:50 UTC | Quanex Building Products CORP NX · Entity 5077 | Tax withholdingCommon Stock | 1,335 | $21.72 | $28,996.20 |
DisclosureSEC source: 0001127602-22-003574 · form4.xml · nonDerivative · entry 1 LIVINGSTON MARK A · CIK 0001651202 · VP CAO Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,265 F1 · kind: Shares were sold to cover taxes due in connection with the lapse of forfeiture restrictions on restricted stock originally granted to the reporting person on February 4, 2019. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:14 UTC | Quanex Building Products CORP NX · Entity 5077 | GrantCommon Stock | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030805 · form4.xml · nonDerivative · entry 1 LIVINGSTON MARK A · CIK 0001651202 · VP CAO Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,600 Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:45 UTC | Quanex Building Products CORP NX · Entity 5077 | GrantCommon Stock | 3,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030594 · form4.xml · nonDerivative · entry 1 LIVINGSTON MARK A · CIK 0001651202 · VP CAO Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,100 Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:37 UTC | Quanex Building Products CORP NX · Entity 5077 | GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-034568 · form4.xml · nonDerivative · entry 1 LIVINGSTON MARK A · CIK 0001651202 · VP CAO Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Read SEC document |
| December 19, 2017 Filed Dec 21, 2017 18:19 UTC | OMEGA PROTEIN CORP OME · Entity 170819 | Disposition to issuerCommon Stock | 6,224 | $22.00 | $136,928.00 |
DisclosureSEC source: 0000899243-17-029417 · doc4.xml · nonDerivative · entry 1 LIVINGSTON MARK A · CIK 0001651202 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Includes shares of common stock (the "Common Stock") of Omega Protein Corporation (the "Company") held by the Reporting Person and awards of shares of restricted Common Stock previously granted, 4,032 shares of which vested immediately prior to the effective time of the Merger (as defined below). F2 · price: On December 19, 2017, pursuant to the Agreement and Plan of Merger dated as of October 5, 2017 (the "Merger Agreement"), by and among the Company, Cooke Inc. ("Cooke") and Alpha MergerSub, Inc. ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger") with the Company continuing as the surviving entity and a wholly-owned indirect subsidiary of Cooke. Pursuant to the Merger Agreement, each share of Common Stock of the Company issued and outstanding immediately prior to the effective time of the merger was automatically cancelled and converted into the right to the receive $22.00 in cash, less any required tax withholdings. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 16:11 UTC | OMEGA PROTEIN CORP OME · Entity 170819 | Tax withholdingCommon Stock | 323 | $15.80 | $5,103.40 |
DisclosureSEC source: 0001209191-17-051049 · doc4.xml · nonDerivative · entry 1 LIVINGSTON MARK A · CIK 0001651202 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,224 F1 · security: Payment of tax liability by withholding Common Stock incident to vesting of Common Stock award issued in accordance with Rule 16b-3. F1 · shares: Payment of tax liability by withholding Common Stock incident to vesting of Common Stock award issued in accordance with Rule 16b-3. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 16:32 UTC | OMEGA PROTEIN CORP OME · Entity 170819 | Tax withholdingCommon Stock | 171 | $19.32 | $3,303.72 |
DisclosureSEC source: 0001209191-17-019869 · doc4.xml · nonDerivative · entry 1 LIVINGSTON MARK A · CIK 0001651202 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,547 F1 · security: Payment of tax liability by withholding Common Stock incident to vesting of Common Stock award issued in accordance with Rule 16b-3. F1 · shares: Payment of tax liability by withholding Common Stock incident to vesting of Common Stock award issued in accordance with Rule 16b-3. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 16:40 UTC | OMEGA PROTEIN CORP OME · Entity 170819 | GrantCommon Stock | 1,565 | $25.55 | $39,985.75 |
DisclosureSEC source: 0001209191-17-015915 · doc4.xml · nonDerivative · entry 1 LIVINGSTON MARK A · CIK 0001651202 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,718 F1 · security: 1,565 - Restricted Stock Award Grant under 2015 Long Term Incentive Plan. F1 · shares: 1,565 - Restricted Stock Award Grant under 2015 Long Term Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.